Published online Sep 25, 2021. doi: 10.5501/wjv.v10.i5.264
Peer-review started: April 21, 2021
First decision: June 7, 2021
Revised: June 21, 2021
Accepted: August 13, 2021
Article in press: August 13, 2021
Published online: September 25, 2021
Processing time: 148 Days and 7.6 Hours
The coronavirus disease 2019 (COVID-19) pandemic has been challenging for healthcare professionals worldwide. One of the populations affected by the pandemic are patients on renal replacement therapy, as kidney disease is an independent risk factor for severe COVID-19 and maintenance dialysis (a life-sustaining therapy) cannot be interrupted in the vast majority of cases. Over the past months, several authors and medical societies have published recommendations and guidelines on the management of this population. This article is a comprehensive review regarding the measures to prevent, contain and deal with a COVID-19 pandemic in the dialysis setting. We recapitulate the epidemiology and pathophysiology of COVID-19 in kidney dysfunction and present the main recommendations concerning the screening of healthcare personnel, dialysis patients and visitors as well as measures to improve the safety of the dialysis facilities’ environments. In addition to preventive measures, this article briefly describes actions directed towards management of an outbreak of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) within a dialysis facility, the management of complications in dialysis patients with COVID-19 and overall data regarding the management of children with kidney disease.
Core Tip: Dialysis patients are more vulnerable to develop severe coronavirus disease 2019 (COVID-19) infection. To minimize risks, some measures should be followed by dialysis units, healthcare personnel, patients and visitors. Until vaccination against COVID-19 is widely available to dialysis patients worldwide, an evidence-based approach is required to avoid the spread of the virus and consequently more death of patients.